Lipocine Balance Sheet Health
Financial Health criteria checks 5/6
Lipocine has a total shareholder equity of $32.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $34.0M and $2.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$28.87m |
Equity | US$31.96m |
Total liabilities | US$2.06m |
Total assets | US$34.02m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2VT0's short term assets ($30.6M) exceed its short term liabilities ($1.9M).
Long Term Liabilities: 2VT0's short term assets ($30.6M) exceed its long term liabilities ($131.7K).
Debt to Equity History and Analysis
Debt Level: 2VT0 is debt free.
Reducing Debt: 2VT0 has no debt compared to 5 years ago when its debt to equity ratio was 60.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2VT0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2VT0 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.